Clinical Trial Update: Feasibility Study of Acute Myelogenous Leukemia mRNA Plus Lysate Loaded Dendritic Cell Vaccines [Phase 1]

View source ↗

Summary

Phase 1 feasibility study evaluating an mRNA plus lysate loaded dendritic cell vaccine for acute myeloid leukemia; the trial has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• mRNA plus lysate loaded dendritic cell vaccine

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Leukemia | Phase 1 | Status: TERMINATED